Your browser doesn't support javascript.
loading
Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis.
Shi, Hongwei; Tang, Heng; Ai, Wen; Zeng, Qingfu; Yang, Hong; Zhu, Fengqing; Wei, Yunjie; Feng, Rui; Wen, Li; Pu, Peng; He, Quan.
Affiliation
  • Shi H; Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Tang H; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Ai W; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Zeng Q; Shenzhen Nanshan District People's Hospital, Shenzhen, China.
  • Yang H; Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Zhu F; Department of Endocrine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Wei Y; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Feng R; Department of Cardiology, Hubei Shiyan Taihe Hospital, Shiyan, China.
  • Wen L; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Pu P; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • He Q; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Front Pharmacol ; 12: 796551, 2021.
Article in En | MEDLINE | ID: mdl-34858195

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2021 Document type: Article